Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 22Completed 4Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Head & Neck 1

Conditions

Squamous Non-Small Cell Lung Cancer SqNSCLC 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 63Cisplatin 40Pemetrexed 38Drug Therapy 37osimertinib 23anlotinib 22Etoposide 20tislelizumab 17Radiotherapy 17Paclitaxel 17Surgical Procedures, Operative 16pembrolizumab 15toripalimab 14130-nm albumin-bound paclitaxel 14aflutinib 13Docetaxel 13Bevacizumab 12sintilimab 10Specimen Handling 10Magnetic Resonance Spectroscopy 10Injections 9durvalumab 8cemiplimab 8Radiosurgery 8Platinum 8PM 01183 8Immunotherapy 8atezolizumab 7Platinum Compounds 7Blood Specimen Collection 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Endostatins × Thoracic × Clear all
NCT06747169 2024-12-27

Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study

Second Affiliated Hospital of Zunyi Medical University

Phase 2 Not yet recruiting
32 enrolled
Thoracic

Squamous Non-Small Cell Lung Cancer SqNSCLC

NCT06618391 2024-10-01

Local Injection and Systemic Therapy in the Treatment of NSCLC.

Henan Cancer Hospital

Phase 2 Not yet recruiting
84 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡